Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AgelessRx vs AM Rx

AgelessRx
Graded #24

Higher grade

vs+34.699999999999996
AM Rx
Graded #491

Lower grade

The verdict

AgelessRx takes it — 84.3/100 to 49.6/100.

AgelessRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Among the lowest compounded-semaglutide pricing, with some brand-name access.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAgelessRx +40
90
50
Dose & formulationAgelessRx +15
80
65
Clinical oversightAgelessRx +42
83
41
Labs & monitoringAgelessRx +33
82
49
FulfillmentAgelessRx +26
84
58
Contract termsAgelessRx +65
85
20
AgelessRx · left barAM Rx · right bar

The numbers

MetricAgelessRxAM Rx
WeighScore84.3/10049.6/100
GradeBC
Scorecard rank#24#491
Semaglutide$139/mo$151/mo (quarterly plan, plus a separate fee, compounded)
TirzepatideNot disclosedNot disclosed
CoverageNot disclosedCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
AgelessRx

Graded #24 · B

Strengths

  • Low-end semaglutide pricing
  • Some brand-name access
  • Established brand

Where it loses points

  • Tirzepatide pricing not disclosed
  • States not disclosed
AM Rx

Graded #491 · C

Strengths

  • Insurance coordination for brand-name GLP-1s — as low as $25/mo
  • All four major brand-name GLP-1s available (Ozempic, Wegovy, Zepbound, Mounjaro)
  • HSA and FSA accepted
  • Video visits available with providers averaging 10+ years' experience
  • Compounded semaglutide from $151/mo on the quarterly plan

Where it loses points

  • Active FTC/DOJ lawsuit over deceptive billing and subscription practices
  • Novo Nordisk false-advertising lawsuit (Aug 2025)
  • Parent company Zealthy holds a BBB D- rating with 2,370+ complaints
  • Trustpilot 2.0/5, with 85% one-star reviews citing billing disputes and unreachable support
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard